Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell S Buckley

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of Pharmacy Practice|February 23, 2019
Moderate to Severe Acute Respiratory Distress Syndrome Management Strategies: A Narrative ReviewMitchell S Buckley, Amy L Dzierba, Justin Muir, et al.
Pharmacotherapy|April 16, 2014
A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndromeAmy L Dzierba, Erik E Abel, Mitchell S Buckley, et al.
The Annals of Pharmacotherapy|January 20, 2016
Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill PatientsMitchell S Buckley, Brittany A Reeves, Jeffrey F Barletta, et al.
The Annals of Pharmacotherapy|April 17, 2016
Reply: Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill PatientsMitchell S Buckley, Brittany A Kaufman, Jeffrey F Barletta, et al.
Journal of Intensive Care Medicine|November 2, 2019
Adverse Hemodynamic Events Associated With Concomitant Dexmedetomidine and Propofol for Sedation in Mechanically Ventilated ICU PatientsMitchell S Buckley, Sumit K Agarwal, Robert MacLaren, et al.
Hospital Pharmacy|March 28, 2020
Hyperoncotic Albumin Reduces Net Fluid Loss Associated With HemodialysisMitchell S Buckley, Brian L Erstad, Jake M Lansburg, et al.
Drug, Healthcare and Patient Safety|June 25, 2011
Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacyMitchell S Buckley, Robin L Staib, Laura M Wicks, et al.
Critical Care Medicine|May 11, 2016
Stress Ulcer ProphylaxisJeffrey F Barletta, Jeffrey J Bruno, Mitchell S Buckley, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 25, 2022
Comparison of 2 different inhaled epoprostenol dosing strategies for acute respiratory distress syndrome in critically ill adults: Weight-based vs fixed-dose administrationMitchell S Buckley, Angel Mendez, John J Radosevich, et al.
Journal of Intensive Care Medicine|March 6, 2020
Comparison of Fixed-Dose Inhaled Epoprostenol and Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome in Critically Ill AdultsMitchell S Buckley, Sumit K Agarwal, Roxanne Garcia-Orr, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of Pharmacy Practice|February 23, 2019
Moderate to Severe Acute Respiratory Distress Syndrome Management Strategies: A Narrative ReviewMitchell S Buckley, Amy L Dzierba, Justin Muir, et al.
Pharmacotherapy|April 16, 2014
A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndromeAmy L Dzierba, Erik E Abel, Mitchell S Buckley, et al.
The Annals of Pharmacotherapy|January 20, 2016
Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill PatientsMitchell S Buckley, Brittany A Reeves, Jeffrey F Barletta, et al.
The Annals of Pharmacotherapy|April 17, 2016
Reply: Correlation of Free and Total Phenytoin Serum Concentrations in Critically Ill PatientsMitchell S Buckley, Brittany A Kaufman, Jeffrey F Barletta, et al.
Journal of Intensive Care Medicine|November 2, 2019
Adverse Hemodynamic Events Associated With Concomitant Dexmedetomidine and Propofol for Sedation in Mechanically Ventilated ICU PatientsMitchell S Buckley, Sumit K Agarwal, Robert MacLaren, et al.
Hospital Pharmacy|March 28, 2020
Hyperoncotic Albumin Reduces Net Fluid Loss Associated With HemodialysisMitchell S Buckley, Brian L Erstad, Jake M Lansburg, et al.
Drug, Healthcare and Patient Safety|June 25, 2011
Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacyMitchell S Buckley, Robin L Staib, Laura M Wicks, et al.
Critical Care Medicine|May 11, 2016
Stress Ulcer ProphylaxisJeffrey F Barletta, Jeffrey J Bruno, Mitchell S Buckley, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 25, 2022
Comparison of 2 different inhaled epoprostenol dosing strategies for acute respiratory distress syndrome in critically ill adults: Weight-based vs fixed-dose administrationMitchell S Buckley, Angel Mendez, John J Radosevich, et al.
Journal of Intensive Care Medicine|March 6, 2020
Comparison of Fixed-Dose Inhaled Epoprostenol and Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome in Critically Ill AdultsMitchell S Buckley, Sumit K Agarwal, Roxanne Garcia-Orr, et al.
Pageof 6